期刊文献+

肿瘤血管阻断剂黄酮-8-乙酸类衍生物的三维定量关系研究 被引量:2

3D-QSAR Studies of Flavone-8-acetic Acid Analoges Disrupting Tumour Blood Vessels
原文传递
导出
摘要 选择了肿瘤血管阻断剂黄酮-8-乙酸类衍生物,采用比较分子力场分析(CoMFA)和比较分子相似性指数分析(CoMSIA)方法进行三维定量构效关系的研究.33个化合物建立了预测模型,6个化合物作为训练集进行模型验证.其中CoMFA模型的交叉验证系数q2=0.621,最佳主成分数为4,标准偏差spress=0.345,非交叉相关系数r2=0.945,标准偏差s=0.131,F=120.455.CoMSIA模型的交叉验证系数q2=0.700,最佳主成分数为5,标准偏差spress=0.312,非交叉相关系数r2=0.946,标准偏差s=0.133,F=94.193.计算结果表明,构建的CoMFA和CoMSIA模型具有良好的预测能力,可用于指导该类化合物的设计. Flavone-8-acetic acid analoges disrupting Tumour blood vessels were applied to 3D-QSAR analyses using the comparative molecular field analysis(CoMFA) and comparative molecular similarity in-dex analysis(CoMSIA) methods.Thirty-three compounds were served to establish the predicting models,which were validated by evaluation of the test set of six compounds.The best predictions were obtained with the CoMFA steric,electrostatic fields(q2=0.621,n=4,spress=0.345,r2=0.945,s=0.131,F=120.455) and with the CoMSIA combined steric and hydrophobic fields(q2=0.700,n=5,spress=0.312,r2=0.946,s=0.133,F=94.193).With the guidance of the obtained model,some compounds with high activity would be designed.
出处 《化学学报》 SCIE CAS CSCD 北大核心 2011年第2期231-238,共8页 Acta Chimica Sinica
基金 广东省医学科学技术研究基金(No.B2008103) 广东省自然科学基金(No.9451051501002541)资助项目
关键词 肿瘤血管阻断剂 黄酮-8-乙酸 比较分子力场分析 比较分子相似性指数分析 vascular disrupting agents flavone-8-acetic acid CoMFA CoMSIA
  • 相关文献

参考文献6

二级参考文献40

  • 1张金桐,宋仰弟.黄酮类化合物的生物活性与电子结构关系的量子化学研究[J].山西农业大学学报,1993,13(2):134-140. 被引量:26
  • 2盛春泉,张万年,张珉,宋云龙,陈军,朱杰,季海涛,姚建忠,缪震元.新型三唑类抗真菌化合物的三维定量构效关系研究[J].化学学报,2005,63(7):617-624. 被引量:7
  • 3胡春,丁霄霖.黄酮类化合物在不同氧化体系中的抗氧化作用研究[J].食品与发酵工业,1996(3):46-53. 被引量:140
  • 4胡春.黄酮类化合物的抗氧化性质[J].中国油脂,1996,21(4):18-21. 被引量:100
  • 5裴剑锋 周家驹.化学学报(Huaxue Xuebao),2002,60:973-973.
  • 6黄酮类化合物清除过氧化氢自由基作用的构效关系[J].国外医药:植物药分册,2001,1(1):137-137.
  • 7Cameron NE,Cotter MA.Basso M,et al.Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function,nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats[J].Diabetologia,1997,40:271-281
  • 8Petrash JM.All in the family:aldose reductase and closely related aldoketo reductases[J].CMLS,Cell.Mol.Life Sci.2004,61:739-749
  • 9Rastelli G,Costantino L.Moleccular dynamics simulations of the structure of aldose reductase complexed with the inhibitor tolrestat[J].bioorganic & Medicinal Chemistry Letters 1998,8:641-646
  • 10Klebe G,Abraham U,Mietzner T.Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity[J].J.Med.Chem.1994,37 (24):4130-4146

共引文献105

同被引文献21

  • 1李燕,王永华,杨凌,张述伟,蒋达,刘长厚,杨胜利.黄酮衍生物作为P糖蛋白抑制剂的构效关系研究[J].大连理工大学学报,2007,47(1):15-20. 被引量:5
  • 2WALL M E,WANI M C,COOK C E,et al. [J]. Journal of the American Chemical Society, 1966,88(16):3888-3890.
  • 3LAVERGNE O,DEMARQUARY D,KASPRZYK P G, et al. [J]. Annals of the New York Academy of Sciences, 2000,922: 100-111.
  • 4LAVERGNE O, LESUEUR-GINOT L, RODAS F P, et al.[J].Journal of Medicinal Chemistry, 1998,41 (27) : 5410-5419.
  • 5LESUEUR-GINOT L,DEMARQUAY D,KISS R,et al.[J].Cancer Research,1999,59(12) :2939-2943.
  • 6Bailly C. [J].Critical Reviews in Oncology/Hematology, 2003,45(1) :91-108.
  • 7TEICHER B A.[J]. Biochemical Pharmacology,2008,75(6) :1262-1271.
  • 8POMMIER Y. [J]. Chemical Reviews,2009,109(7) : 2894-2902.
  • 9DEMARQUAY D, HUCHET M, COULOMB H, et al. [J].Cancer Research, 2004,64 (14) : 4942.
  • 10CRAMER LII R D, PATTERSON D E,BUNCE J D. [J]. Journal of the American Chemical Society, 1988,110(18) : 5959- 5967.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部